Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

504 public trials 140 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Not Yet Recruiting

Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy of Relapsed/Refractory B-Cell Lymphoma

NCT07546630

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase I Clinical Study on the Safety and Efficacy of CY-219 CAR-T Cell Injection in the Treatment of Relapsed/Refractory B-Cell Lymphoma

NCT07539688

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

NCT07520006

Conditions: B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

NCT07516093

Conditions: B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

NCT07506668

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

NCT07502872

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +10 more
Locations: Rhode Island Hospital Providence, Rhode Island, United States

View Trial Details

Not Yet Recruiting

Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

NCT07477366

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma

NCT07367685

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The Second Affiliated Hospital of Fujian Medical University Quanzhou, Fujian, China

View Trial Details

Not Yet Recruiting

Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT07345741

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, China

View Trial Details

Not Yet Recruiting

Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL

NCT07334574

Conditions: B-cell Non-Hodgkin's Lymphoma (B-NHL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Ruijin Hospital Shanghai, China

View Trial Details

Lymphoma, B-Cell

Lymphoma, B-Cell trial results

Related conditions